On April 19, 2025, Legal Vision hosted in Beijing the "Legal Vision Legal Service Innovation & Development Forum and the Spring Release Ceremony of 2025 Legal Vision Guide ," which was guided by the China Justice Big Data Institute. During the forum, Legal Vision officially released the Premium Legal Service Brand Guide (2024): Biopharmaceutical and Medical, which aims to deeply explore and showcase outstanding legal service brands and lawyer teams in the biopharmaceutical and healthcare industries.
Han Kun partner Aaron Gu was honored as Legal Vision's 2024 "Brand Star in Biopharmaceutical and Medical: Leading Lawyer" for his professional reputation, industry influence, and strong client feedback in this specialized field. This award, the highest individual honor in the guide, recognizes legal practitioners with exceptional expertise and comprehensive impact.
Profile
Mr. Gu focuses on corporate, regulatory compliance and transactional services for the life sciences, biopharmaceutical, medical, and healthcare industries, including biosecurity and human genetic resource issues, clinical trial matters, product marketing authorizations, GxP compliance, drug licensing and collaboration (license-in/out), as well as regulatory issues involved in venture capital and private equity investments, mergers and acquisitions, and foreign and outbound investments in the life sciences industries. Mr. Gu also provides advocacy advice for draft laws and regulations released by the NMPA and other Chinese governmental authorities. Specifically, Mr. Gu's practice covers a full range of products including drugs (biologics and chemical drugs), medical devices, IVDs, cosmetics, general foods, special foods (health foods, foods for special medical purposes, and infant formulas), animal drugs, and animal foods.
Mr. Gu has extensive experience representing various types of companies in the life sciences industry, including major multinational pharmaceutical firms, leading Chinese innovative drug and biotechnology companies, as well as top domestic and international investment institutions. Acknowledged for his outstanding and professional legal services in life sciences and healthcare, Mr. Gu has received numerous accolades from prestigious institutions such as Chambers and Partners, The Legal 500, China Business Law Journal (CBLJ), Lex Falcon Global Awards, Asian Legal Business and Mondaq. Additionally, Mr. Gu has been interviewed multiple times by media such as 36Kr, Caixin, Yicai, E Drug Manager, Discover Magazine, International Pharmaceutical News, Het Financieele Dagblad (The Financial Daily, a major Dutch media outlet ), Jiemian, the Economic Observer, Shenlan Outlook, and Thomson Reuters (in alphabetical order).
The forum gathered leading experts and practitioners in the legal services industry to discuss trending topics in professional field development and innovation. Legal Vision Research Center conducted a rigorous evaluation process, combining application materials, expert reviews, peer evaluations, and client feedback to finalize the 2024 "Brand Star" honorees (Leading Lawyer, Established Lawyer, Dedicated Lawyer, Rising Star Lawyer) in the biopharmaceutical and healthcare industries.
